DOI: 10.12890/2025_005764

Guillain-Barré syndrome as the initial clinical manifestation of Hodgkin’s lymphoma

Authors

  • Vasileios Petrakis 2nd University Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece
  • Georgios Tartanis Department of Neurology, University General Hospital of Alexandroupolis, Alexandroupolis, Greece
  • Soultana Tsakaldimi Department of Neurology, University General Hospital of Alexandroupolis, Alexandroupolis, Greece
  • Ioulia Dragoumani 2nd University Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece
  • Athina Danadaki Department of Neurology, University General Hospital of Alexandroupolis, Alexandroupolis, Greece
  • Christoforos Roubakis University Department of Haematology, University General Hospital of Alexandroupolis, Alexandroupolis, Greece
  • Christina Aggelopoulou Department of Neurology, University General Hospital of Alexandroupolis, Alexandroupolis, Greece

vasilispetrakis1994@gmail.com

Keywords

Guillain-Barré syndrome (GBS), Hodgkin’s lymphoma, neuropathy, lymphoma, paraneoplastic syndrome

Abstract

Background: There are a considerable number of published cases reporting the clinical development of neurological symptoms in people diagnosed with Hodgkin’s lymphoma (HL). However, Guillain-Barré syndrome (GBS) as the initial clinical manifestation of HL is extremely rare. We describe a complex case of GBS with the subsequent diagnosis approach leading to the diagnosis of HL.
Case report: A 32-year-old male presented to the emergency department due to paraesthesia of the upper and lower extremities and muscle weakness of the lower extremities that began 1 week earlier, and diplopia observed during last 24 hours. The neurological examination revealed paresis of the left abductor nerve, moderate paraparesis, stocking-glove hypoesthesia, absence of tendon reflexes in the lower extremities, disturbance of deep sensory, sensory ataxia, dysesthesias and neuropathic pain of extremities. The lumbar puncture revealed albuminocytologic dissociation in cerebrospinal fluid. In the electrophysiological examination mainly motor demyelinating polyradiculoneuritis was reported. These findings supported the diagnosis of GBS and intravenous immunoglobulin (2 g/kg) was administered over 5 days. However, the patient deteriorated and developed more severe neurological symptoms including paresis of left peripheral facial nerve, right abductor nerve, oculomotor nerve bilaterally and severe tetraparesis. The patient had seven sessions of plasmapheresis with partial resolution of the neurological symptoms. A full body computed tomography scan was performed revealing enlarged mediastinal and mesenteric lymph nodes and multiple lesions in the splenic and hepatic parenchyma indicative of HL. Although a bone marrow biopsy was negative, a liver biopsy was performed, and the diagnosis of HL was confirmed. The patient was treated with chemotherapy and the neurological symptoms resolved completely
Conclusion: This case report highlights the need to include HL in the differential diagnosis in cases of GBS, although it is a rare phenomenon with a possible immunological basis. Early diagnosis and initiation of the appropriate treatment are vital in order to achieve the remission of neurological symptoms and signs.

View the entire article

Downloads

References

  1. Al IO, Koc B, Bayram C, Pasli EU, Yildiz EP, Aycicek A, Caliskan M, Ozdemir GN. Variant Guillain-Barré syndrome in a patient with Hodgkin lymphoma: AMSAN. Turk Pediatri Ars 2018;53:263-266. doi: 10.5152/TurkPediatriArs.2018.4763
  2. Gandhi AG, Maisuria BA, Patel RG, Arora B. General consideration of Guilliain Barre Syndrome. IJPSR 2012;3:4135–4141. doi:10.13040/IJPSR.0975-8232.3(11).4135-41
  3. Al-Attas AA, Aldayel AY, Al Najjar SA, Alkhonezan SM. Guillain-Barré Syndrome Heralding the Diagnosis of Hodgkin Lymphoma: A Case Report. Case Rep Neurol 2020;12:365-372. doi: 10.1159/000509681
  4. Graus F, Ariño H, Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood 2014;123:3230–3238. doi: 10.1182/blood-2014-03-537506
  5. Tüzün E. Nörolojik tutulumla seyreden paraneoplastik sendromlar. Klinik gelisim dergisi 2010;23:71–77.
  6. Polo-Romero FJ, Sánchez-Beteta P, Perona-Buendía P, Pérez-García AM. Guillain-Barré syndrome as first presentation of non-Hodgkin lymphoma. Neurologia 2012;27:511-513. English, Spanish. doi: 10.1016/j.nrl.2011.10.009
  7. Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK. Guillain-Barré syndrome and Hodgkin’s disease: three cases with immunological studies. Ann Neurol 1977;1:72–78. doi: 10.1002/ana.410010107
  8. Julien J, Vital C, Aupy G, Lagueny A, Darriet D, Brechenmacher C. Guillain-Barré syndrome and Hodgkin’s disease—ultrastructural study of a peripheral nerve. J Neurol Sci 1980;45:23-27. doi: 10.1016/s0022-510x(80)80003-7
  9. Cros D, Harris NL, Hedley-Whyte ET. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1990. A 66-year-old man with demyelinative neuropathy and a retroperitoneal mass. N Engl J Med 1990;323:895–908. doi: 10.1056/NEJM199009273231308
  10. Anderson D, Beecher G, Steve TA, Jen H, Camicioli R, Zochodne DW. Neurological Nuance: hodgkin lymphoma presenting with Guillain-Barrè syndrome. Muscle Nerve 2017;55:601–604. doi: 10.1002/mus.25439
  11. Girma B, Farkas DK, Laugesen K, Skajaa N, Henderson VW, Boffetta P, Sørensen HT. Cancer Diagnosis and Prognosis After Guillain-Barré Syndrome: A Population-Based Cohort Study. Clin Epidemiol 2022;14:871-878. doi: 10.2147/CLEP.S369908

Published

2025-09-03

Issue

Vol. 12 No. 10 (2025)

Categories

How to Cite

1.
Petrakis V, Tartanis G, Tsakaldimi S, Dragoumani I, Danadaki A, Roubakis C, et al. Guillain-Barré syndrome as the initial clinical manifestation of Hodgkin’s lymphoma. EJCRIM [Internet]. 2025 Sep. 3 [cited 2026 Nov. 3];12(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5764

Most read articles by the same author(s)